Isthmus Partners LLC raised its position in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 7.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 525,886 shares of the real estate investment trust's stock after acquiring an additional 36,357 shares during the quarter. Isthmus Partners LLC owned approximately 0.08% of Healthpeak Properties worth $10,633,000 as of its most recent SEC filing.
A number of other hedge funds also recently added to or reduced their stakes in the business. Mizuho Bank Ltd. purchased a new position in shares of Healthpeak Properties in the 4th quarter valued at about $28,000. Harvest Fund Management Co. Ltd purchased a new position in Healthpeak Properties during the 4th quarter worth approximately $30,000. Future Financial Wealth Managment LLC purchased a new position in Healthpeak Properties during the 1st quarter worth approximately $30,000. S.A. Mason LLC grew its stake in shares of Healthpeak Properties by 160.9% in the 1st quarter. S.A. Mason LLC now owns 1,500 shares of the real estate investment trust's stock valued at $30,000 after purchasing an additional 925 shares during the last quarter. Finally, Covestor Ltd grew its stake in shares of Healthpeak Properties by 173.8% in the 4th quarter. Covestor Ltd now owns 1,815 shares of the real estate investment trust's stock valued at $37,000 after purchasing an additional 1,152 shares during the last quarter. 93.57% of the stock is currently owned by institutional investors and hedge funds.
Healthpeak Properties Stock Down 0.5%
Shares of NYSE DOC traded down $0.10 on Friday, hitting $18.44. The company had a trading volume of 5,349,015 shares, compared to its average volume of 5,356,732. The firm has a market capitalization of $12.81 billion, a P/E ratio of 46.10, a PEG ratio of 2.10 and a beta of 1.03. Healthpeak Properties, Inc. has a 12-month low of $16.64 and a 12-month high of $23.26. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 1.01. The business has a 50 day moving average of $17.47 and a two-hundred day moving average of $18.96.
Healthpeak Properties (NYSE:DOC - Get Free Report) last released its earnings results on Thursday, April 24th. The real estate investment trust reported $0.46 EPS for the quarter, hitting analysts' consensus estimates of $0.46. The company had revenue of $702.89 million for the quarter, compared to the consensus estimate of $690.76 million. Healthpeak Properties had a return on equity of 3.06% and a net margin of 9.99%. Healthpeak Properties's quarterly revenue was up 15.9% compared to the same quarter last year. During the same quarter last year, the business posted $0.45 EPS. As a group, equities research analysts forecast that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current fiscal year.
Healthpeak Properties Dividend Announcement
The firm also recently announced a monthly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Friday, September 19th will be paid a dividend of $0.1017 per share. This represents a $1.22 annualized dividend and a yield of 6.62%. The ex-dividend date is Friday, September 19th. Healthpeak Properties's payout ratio is currently 305.00%.
Insider Buying and Selling at Healthpeak Properties
In other news, Director John T. Thomas acquired 4,200 shares of the company's stock in a transaction dated Monday, April 28th. The shares were bought at an average price of $17.84 per share, with a total value of $74,928.00. Following the purchase, the director owned 813,566 shares of the company's stock, valued at approximately $14,514,017.44. This represents a 0.52% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Scott M. Brinker bought 2,750 shares of the business's stock in a transaction dated Friday, May 9th. The shares were bought at an average cost of $17.39 per share, for a total transaction of $47,822.50. Following the completion of the transaction, the chief executive officer directly owned 204,613 shares of the company's stock, valued at $3,558,220.07. This trade represents a 1.36% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have acquired 29,764 shares of company stock valued at $521,909 in the last quarter. Corporate insiders own 0.23% of the company's stock.
Analyst Upgrades and Downgrades
A number of brokerages recently weighed in on DOC. Wells Fargo & Company dropped their price objective on Healthpeak Properties from $22.00 to $20.00 and set an "equal weight" rating on the stock in a report on Monday, June 2nd. Wedbush reduced their price objective on Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a report on Monday, April 28th. Scotiabank cut their price target on Healthpeak Properties from $23.00 to $21.00 and set a "sector outperform" rating for the company in a report on Monday, May 12th. Wall Street Zen lowered Healthpeak Properties from a "hold" rating to a "sell" rating in a research note on Monday, July 7th. Finally, Evercore ISI dropped their target price on Healthpeak Properties from $23.00 to $21.00 and set an "outperform" rating for the company in a research note on Monday, April 28th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and nine have given a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $23.27.
View Our Latest Report on DOC
Healthpeak Properties Profile
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Further Reading

Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.